<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="161328">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01747395</url>
  </required_header>
  <id_info>
    <org_study_id>ICRESP814/10</org_study_id>
    <nct_id>NCT01747395</nct_id>
  </id_info>
  <brief_title>Exercise Training Associated With Inspiratory Muscle Training in Heart Failure</brief_title>
  <official_title>Effects of Aerobic Exercise Training Associated With Inspiratory Muscle Training in Patients With Heart Failure</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Sao Paulo General Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Federal University of São Paulo</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Sao Paulo General Hospital</source>
  <oversight_info>
    <authority>Brazil: Ethics Committee</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators hypothesize that aerobic exercise training associated with respiratory
      muscle training will cause additional benefits in the autonomic control and respiratory
      function compared to isolated exercise training or respiratory training in chronic heart
      failure patients.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>August 2012</start_date>
  <completion_date type="Anticipated">December 2015</completion_date>
  <primary_completion_date type="Anticipated">December 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Autonomic control</measure>
    <time_frame>4 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Exercise training associated with inspiratory muscle training will reduce sympathetic nerve activity.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Respiratory function</measure>
    <time_frame>4 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Exercise training associated with inspiratory muscle training will improve respiratory muscle strength and resistance.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Functional Capacity</measure>
    <time_frame>4 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Exercise training associated with inspiratory muscle training will improve peak oxygen consumption</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life</measure>
    <time_frame>4 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Exercise training associated with inspiratory muscle training will improve quality of life</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood inflammatory markers</measure>
    <time_frame>4 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Exercise training associated with inspiratory muscle training will reduces blood inflammatory markers</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Muscular evaluation</measure>
    <time_frame>4 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Exercise training associated with inspiratory muscle training will increase skeletal muscle strength</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Heart Failure</condition>
  <arm_group>
    <arm_group_label>Control Group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Aerobic Exercise Training</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Isolate Aerobic Exercise Training for 4 months</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Inspiratory Muscle Training</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Isolate Inspiratory Muscle Training for 4 months</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Aerobic Exercise Training + Inspiratory Muscle Training</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Aerobic Exercise Training associated with Inspiratory Muscle Training for 4 months</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Physical exercise</intervention_name>
    <arm_group_label>Aerobic Exercise Training</arm_group_label>
    <arm_group_label>Inspiratory Muscle Training</arm_group_label>
    <arm_group_label>Aerobic Exercise Training + Inspiratory Muscle Training</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with systolic heart failure and New York Heart Association (NYHA) class
             II-III

          -  Left ventricular ejection fraction less than 40%

          -  Peak Oxygen Consumption less than 20 ml/Kg/min

        Exclusion Criteria:

          -  Chronic Obstructive Pulmonary Disease

          -  Neuromuscular, Orthopedic, Neurologic and Neoplastic Diseases

          -  Recent myocardial infarction or cardiac surgery (less than 6 months)

          -  Unstable angina pectoris

          -  Atrial Fibrillation

          -  Pacemakers users

          -  Actual Smoker

          -  Pregnant

          -  Changing medication or hospital admission
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Carlos Eduardo Negrão</last_name>
    <role>Principal Investigator</role>
    <affiliation>InCor, HCFMUSP</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Carlos Eduardo Negrão</last_name>
    <phone>21 11 26615699</phone>
    <email>cndnegrao@incor.usp.br</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Patricia Fernandes Trevizan</last_name>
    <phone>21 11 2661 5099</phone>
    <email>patricia_trevizan@yahoo.com.br</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Instituto do Coração - HC/FMUSP</name>
      <address>
        <city>São Paulo</city>
        <state>SP</state>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Patricia Trevizan</last_name>
      <phone>21 11 2661 5099</phone>
      <email>patricia_trevizan@yahoo.com.br</email>
    </contact>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>December 2012</verification_date>
  <lastchanged_date>December 11, 2012</lastchanged_date>
  <firstreceived_date>December 6, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Sao Paulo General Hospital</investigator_affiliation>
    <investigator_full_name>Patricia Fernandes Trevizan</investigator_full_name>
    <investigator_title>BS</investigator_title>
  </responsible_party>
  <keyword>Heart Failure</keyword>
  <keyword>Exercise and Physical Fitness</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Respiratory Aspiration</mesh_term>
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
